<DOC>
	<DOCNO>NCT01531023</DOCNO>
	<brief_summary>The prevalence extend spectrum beta-lactamase ( ESBL ) produce bacteria find urine sample culture increase past decade . The study hypothesis assess clinical microbiological outcome pivmecillinam treatment ESBL produce E. coli K. Pneumoni , well observe clinical microbiological outcome group bacteria treat antiinfectious agent . Samples gather primary care setting .</brief_summary>
	<brief_title>Treatment Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections General Practice</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<criteria>All patient urinary sample take primary care set show significant growth ESBL produce E. coli . Above age 16 . Sample patient hospital care live nursing home facility . Inability understand sign information leaflet .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Extended-Spectrum Beta-lactamase Producing Bacteria</keyword>
</DOC>